The international requirement for health technology appraisals has placed health economics in the mainstream, near the top of every organisational priority list. Accordingly, healthcare manufacturers are focused, from the very first ventures into clinical development, on the need for their products to be cost-effective. Without data to back up such claims, international market access agencies have the power to make or break a technology’s success in a particular country.

CATALYST undertakes health technology appraisals, which in the past have resulted in successful submissions to many agencies.